Evaluation of polymorphisms of matrix metalloproteinases genes in prostate cancer / Avaliação de polimorfismos dos genes das metaloproteinases da matriz no câncer de próstata

AUTOR(ES)

Sabrina Thalita dos Reis

DATA DE PUBLICAÇÃO

2008

RESUMO

Introduction: Prostate cancer (PCa) is the most frequent tumor in males in Brazil. Research has been directed for the identification of molecular markers that can predict the PCa predisposition and prognosis. Single nucleotide polymorphisms (SNPs) are genome variations, present in a frequency of 1% or more. The matrix metalloproteinases (MMPs) are a family of enzymes responsible for the degradation of extracellular matrix. SNPs have been demonstrated in the promoter region of these genes and have been associated with development and progression of some cancers. Objective: To investigate the correlation between polymorphisms of MMP1, 2, 7, 9 with susceptibility and classical prognostic parameters in PCa. Patients and methods: The sample is constituted by normal tissue of 100 patients with PCa, and 100 healthy men as controls (serum). DNA genomic was extracted from paraffin blocks and serum using conventional protocols. The DNA sequence containing the polymorphic sites was amplified by Real-Time polymerase chain reaction, using fluorescent probes (Taqman®). The allelic frequency was calculated and the comparison between the groups was made using the qui-square test with value of significance of 0.05. Results: The polymorphic homozygote genotype of the MMP1 was more frequent in the control group than in the PCa (p<0.001). The polymorphic allele of MMP9 was more frequent in the PCa group (p<0.001), and in tumors Gleason6 (p=0,003). The polymorphic allele of MMP2 was more frequent in tumors of higher stage (pT3) (p=0.026) and higher Gleason Score (7) (p=0.042). Conclusion: We have shown that MMP1 polymorphism is more frequent in the control group, than in patients with PCa, it may be associated to protection for the development of PCa. The MMP9 polymorphism was related to higher risk for development of this neoplasia, but associated with lower Gleason score. MMP2 polymorphism was associated with non organconfined disease.

ASSUNTO(S)

neoplasias prostáticas prostatic neoplasm metaloproteinases da matriz prognóstico matrix metalloproteinase diagnóstico prognosis polimorfismo genético polymorphism genetic diagnosis

Documentos Relacionados

• Involvement of matrix metalloproteinases in the rodent ventral prostate development and regression
• Avaliação dos níveis de metaloproteinases da matriz no fluido gengival durante a movimentação dentária ortodôntica
• Modulação androgênica das metaloproteinases de matriz e dos receptores de estrógeno na próstata masculina e feminina de gerbilos
• Influência de polimorfismos genéticos sobre os níveis circulantes das metaloproteinases de matriz extracelular 2 e 9 durante hemodiálise = : Influence of genetic polymorphisms on the circulating levels of the matrix metalloproteinases 2 and 9 during hemodialysis
• Relação dos polimorfismos funcionais dos genes das metaloproteinases de matriz 1, 3 e 9 com insuficiência cardíaca por disfunção sistólica